Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medical Marijuana Tecup topic
No spam. Unsubscribe anytime.
Senate panel hears extensive testimony on expanding Texas Compassionate-Use Program; bill left pending
Summary
House Bill 46, a House-originated bill to amend and expand the Texas Compassionate-Use Program (TCUP), drew extensive testimony from patient advocates, industry representatives, and opponents about access, qualifying conditions, delivery methods and program safeguards.
House Bill 46, a House-originated bill to amend and expand the Texas Compassionate-Use Program (TCUP), drew extended testimony from patient advocates, industry representatives, and opponents before the Senate Committee on State Affairs.
"We're supportive of the conversation between 15-05 and 46 here," said Nico Richardson, CEO of Texas Original Compassion Cultivation, summarizing support from one provider perspective. Supporters urged the committee to add satellite dispensary locations, allow pulmonary inhalation as a delivery method, and expand qualifying conditions and delivery formats (patches, lotions, suppositories, inhalers) to increase patient access and reduce reliance on unregulated markets.
Several patients testified in support, saying current program products and costs leave some patients using black-market sources or going without medicine that works for them. "Thousands of Texans can qualify for TCUP, but they're intimidated by the process and getting recommendations is also daunting," said Karen Reeves, a registered patient and advocate who testified she uses cannabis flower obtained off-market when program products are ineffective for her.
Opponents, including Texas Eagle Forum and Texas Values, urged significant amendments or a no vote, citing concerns about addiction, expanded access for veterans or service members, and potential increases in crime or misuse. Texas Eagle Forum said chronic pain is easily faked and warned against open-ended qualifying conditions; Texas Values warned against expanding access in lieu of addressing underlying health issues through other means.
Sponsor and committee members said HB 46 was a work in progress, that a committee substitute was expected to reconcile House and Senate package bills, and that members had substantive concerns to be addressed. The chair opened public testimony to a sizable panel of registered witnesses and heard from proponents and opponents; the committee closed public testimony and left the bill pending for further drafting and amendment.
Why it matters: supporters said expanding delivery methods, satellite access, and qualifying conditions could provide regulated, reliable medicine for patients and reduce black-market use; opponents warned of public-health and crime risks if access is broadened without stronger guardrails.
